Coroxin (Roxithromycin)

Quick links to important sections

Coroxin (Roxithromycin)

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Coroxin (Roxithromycin)

Property Description
Active ingredient Roxithromycin
Pharmacological class Macrolide group antibiotic
Forms Tablet, Film-coated tablet, Oral suspension, Capsule
General purpose Controlling bacterial infections
Origin Semi-synthetic (Erythromycin derivative)

Coroxin is a prescription-only medicine whose active component is the semi-synthetic macrolide antibiotic, Roxithromycin. This compound is chemically derived from the structure of the naturally occurring antibiotic, erythromycin, and is designed for systemic administration to address infections caused by susceptible bacteria.

Roxithromycin possesses improved stability within the gastrointestinal tract and favorable absorption kinetics compared to the parent macrolide. Roxithromycin is a single active ingredient product, positioning it as a dedicated agent within the macrolide group antibiotic class. Macrolides, including roxithromycin, work by inhibiting protein synthesis in bacteria, an action that is clinically recognized for effectively stopping microbial proliferation.

Roxithromycin is formulated for oral administration and is typically available in multiple forms, including the solid tablet and film-coated tablet, and the liquid oral suspension. The availability of the suspension form is a key feature, allowing for convenient dosing for specific patient groups, such as pediatric patients or individuals who have difficulty swallowing. The overall general purpose of this antibacterial agent is to control infections, such as those of the respiratory tract, by suppressing the growth of harmful microbial organisms. Roxithromycin is effective in controlling a broad range of bacterial pathogens. This efficacy supports its role as a recognized therapeutic option for helping the body resolve bacterial infections.

Regulatory References

  1. National Library of Medicine

What side effects are possible with Coroxin (Roxithromycin)?

Possible side effects and safety information

The official safety profile for Coroxin (Roxithromycin), a macrolide antibiotic, is defined by classifications of adverse reactions based on frequency and the body systems affected, as documented in regulatory sources such as the EMA and FDA. These classifications ensure a clear understanding of the medicine's risk profile, which is strictly focused on officially reported events, without providing clinical advice.

Frequency-Classified Adverse Reactions

The majority of documented effects are categorized as Common, affecting up to 1 in 10 people. These frequently involve Gastrointestinal Disorders such as nausea, vomiting, diarrhea, and abdominal pain, along with central nervous system effects like headache and dizziness. Uncommon effects include various hypersensitivity reactions, such as rash and urticaria.

Rare effects, classified as Rare or Very Rare, include severe conditions such as elevated liver enzymes and hepatitis, as well as severe bullous skin reactions (e.g., Stevens-Johnson Syndrome).

Serious Adverse Reactions and Constraints

The regulatory label highlights rare but clinically significant adverse reactions, particularly affecting the cardiovascular and hepatic systems. These serious adverse reactions include QT-interval prolongation and the potential for a life-threatening heart rhythm disorder known as Torsades de Pointes, along with severe liver injury. These risks contribute to specific regulatory constraints.

Usage is generally Contraindicated in individuals with a known allergy to macrolide antibiotics, those with severe hepatic impairment, or those concurrently taking other medications known to significantly prolong the QT interval. Additionally, some gastrointestinal effects are documented as being more frequently observed at the start of treatment.

Overdose and Emergency Response

Overdose Manifestations and Required Actions

The official regulatory documentation for Roxithromycin establishes a specific profile for overdose based on clinical signs and mandated emergency actions. Documented manifestations associated with an overdose exposure primarily involve the gastrointestinal system, including nausea, vomiting, and diarrhoea. Central nervous system effects such as headache and dizziness are also noted and may become potentiated in the context of overdose.

While the regulatory profile characterizes the drug as having low acute toxicity and notes limited formal experience with overdose cases, immediate emergency action is strictly mandated. Individuals who suspect an overdose must seek immediate medical attention by contacting a doctor, calling a poison control center, or going directly to the nearest hospital Emergency Department. This instruction is required even if the individual exhibits no initial signs of discomfort or poisoning.

Management and Supportive Care

Management procedures are defined as symptomatic and supportive, as regulatory documents explicitly state that no specific antidote is known for Roxithromycin overdose. If the documented symptoms become severe, the management of the overdose must be performed as an emergency in a hospital setting. Treatment may involve measures such as gastric lavage and the administration of activated charcoal, depending on the clinical assessment.

Therapeutic Uses of Coroxin (Roxithromycin)

What Coroxin (Roxithromycin) Treats: Main Uses and Benefits

Coroxin (Roxithromycin) is utilized in clinical settings to provide supportive therapeutic benefit across several key infectious domains. It is applied in situations where symptoms are driven by inflammatory or irritative states, helping to ease the overall symptom burden and contributes to easing discomfort.

The medication is relevant for conditions presenting with systemic or localized discomfort, primarily across respiratory and skin domains. The medication is commonly used across conditions presenting with acute episodes in the respiratory tract (such as bronchitis and certain types of pneumonia), the ear, nose, and throat (ENT) areas (like tonsillitis and otitis media), and skin and soft tissue episodes (including cellulitis and impetigo).

“It is relevant for easing symptomatic relief that may assist patients with difficult acute episodes.”


Supports Symptomatic Relief

Coroxin is commonly used across domains where supportive symptom management is appropriate. It helps address symptom clusters that may become intense or disruptive, such as persistent cough, fever, pain, and swelling, and assists with maintaining functional stability during symptomatic periods.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Coroxin (Roxithromycin) — Official Regulatory Information

The eligibility for using Roxithromycin is strictly defined by regulatory documents, which establish specific populations who must not use the medicine and those who require conditional use.

Eligibility Category Status as Stated in Label
Populations for whom use is contraindicated Individuals with known hypersensitivity to macrolides (e.g., erythromycin) or its excipients. Patients taking vasoconstrictive ergot alkaloids (e.g., ergotamine) or certain QTc-prolonging drugs (e.g., cisapride, pimozide). Patients with known congenital long QT syndrome.
Condition-specific eligibility rules Use is not recommended in patients with severe hepatic insufficiency (liver failure). Use with caution is required in patients with mild to moderate hepatic impairment, and often necessitates a dose reduction.
Age-related eligibility rules Tablets are not recommended for children weighing less than 40 kg. No dosage adjustment is typically required for elderly patients or those with renal impairment.
Pregnancy and lactation eligibility Not recommended during pregnancy (especially first trimester) or lactation, unless the clinical benefit is judged to outweigh the potential risks.

These official regulatory statements establish clear constraints, primarily focusing on allergies, liver function, cardiovascular risks, and concurrent high-risk medications, to define the eligibility profile of the drug.

What should I know about interactions with other medicines?

Coroxin (Roxithromycin) Interactions with other medicines and products

Roxithromycin may interact with several medicinal products, potentially leading to increased blood levels of the co-administered drug and, consequently, an elevated risk of adverse effects.

Contraindicated Combinations

Vasoconstrictive Ergot Alkaloids (e.g., Ergotamine, Dihydroergotamine) must not be used concurrently with roxithromycin. This combination is strictly contraindicated due to the risk of severe vasoconstriction, which can lead to a condition known as "ergotism" with possible necrosis of the extremities.

Combinations Requiring Monitoring/Caution

  • Vitamin K Antagonists (e.g., Warfarin): Concomitant use with roxithromycin may increase the International Normalised Ratio (INR), raising the risk of severe bleeding. Close monitoring of INR is mandatory.
  • Theophylline: Roxithromycin has been shown to cause a slight increase in Theophylline plasma concentrations. While a dosage change is not always required, plasma levels must be monitored, especially in patients who start treatment with high Theophylline levels.
  • Disopyramide: Roxithromycin may increase serum levels of this antiarrhythmic agent, potentially through displacement from protein binding. ECG and, if possible, Disopyramide serum levels must be monitored.
  • QT-prolonging agents: Use caution with drugs that prolong the QT interval, such as Class IA and Class III Antiarrhythmic agents, and certain antihistamines like Astemizole and Pimozide, due to the risk of cardiac arrhythmias.
  • Ciclosporin and Midazolam are also subject to potential increases in plasma concentrations when co-administered with roxithromycin.

Mechanism of Action

Direct Inhibition of Bacterial Protein Synthesis

Coroxin (Roxithromycin) acts as a molecular inhibitor by targeting the 50S ribosomal subunit of the susceptible bacteria. The drug reversibly binds to the 23S ribosomal RNA (rRNA) component, effectively blocking the nascent polypeptide exit tunnel. This blockade halts the crucial ribosomal process of translocation and subsequent protein elongation. The consequence is bacteriostasis, a state where the pathogen's ability to replicate is suppressed due to the inability to synthesize essential functional and structural proteins, facilitating the action of the host's immune mechanisms.


Specialized Distribution and Intracellular Action

Beyond direct ribosomal action, the drug exhibits high affinity for phagocytic cells (e.g., macrophages). These host immune cells actively accumulate the drug and transport it to the site of infection, concentrating the substance locally. This specialized distribution confers an intracellular bactericidal effect against susceptible organisms, particularly those residing within host cells, enhancing the drug's physiological impact at the tissue level.


Mechanism Constraints

The inhibitory mechanism is constrained by bacterial resistance pathways, including the activation of efflux pumps that actively expel the drug from the cell, and enzymatic modification of the 23S rRNA binding site, which structurally prevents Roxithromycin attachment. These counter-mechanisms result in reduced intracellular drug concentration or loss of ribosomal binding.

Dosage and Administration Information

Coroxin (Roxithromycin) is administered exclusively via the oral route and is available in formulations such as 150 mg and 300 mg film-coated tablets. Two primary adult dosing regimens are utilized, both resulting in a total daily dose of 300 mg. The medicine may be taken as one 300 mg tablet once daily or as one 150 mg tablet twice daily.

Administration Requirements

The tablet is taken at least 15 minutes before food or on an empty stomach (more than three hours after a meal) to optimize absorption. The tablets must be swallowed whole with a glass of water.

Treatment duration is typically 5 to 10 days for most infections; however, specific conditions, such as Streptococcal throat infections, require a minimum course of 10 days. The prescribed course is to be completed in full.

Population-Specific Dosing

  • Severe Hepatic Impairment: For patients with documented cirrhotic liver disease, the dosage is reduced by half to 150 mg once daily.
  • Renal Impairment & Older Adults: No general dosage adjustment is required for these populations.
  • Pediatric Dosing: In children, the drug is administered twice daily at a dose of 5 to 8 mg/kg/day.

If a dose is missed, it should be skipped if it is almost time for the next scheduled dose, and a double dose must not be taken to compensate.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Key Findings

Research has explored the relationship between combining Drug A (Alpha-Compound) and Drug B (Beta-Compound) and patient-reported measures of improvement. Studies reported the incidence of adverse events (side effects) in people with mild to moderate symptoms.

This combination was assessed to determine its association with clinical endpoints. Measures of the condition's duration and severity were assessed. A major meta-analysis assessed the change in pain scores, reporting a reduction in 85% of participants.

Regarding patients who do not respond to Drug C alone, initial findings indicate that further research may be warranted.

Always discuss the initiation or discontinuation of any medication with a healthcare provider.


Comparison to Monotherapy Studies

Clinical trials compared this combined therapy to standard single-drug treatments to assess its effect and reported side-effect profiles.

Drug A (Active Ingredient: Alpha-Compound)

Studies evaluating Drug A alone focused on changes in the long-term management of the condition.

  • Dose-Finding Studies: Research examined various doses to determine the acceptable range of administration.
  • Long-Term Assessment: Evaluation of changes in flare-up frequency was conducted.

Drug B (Active Ingredient: Beta-Compound)

Studies evaluating Drug B alone focused on the treatment of acute symptom flare-ups.

  • Effect Studies: Studies examined the speed of observed response to acute symptoms, with findings reported within 2 hours of administration.
  • Duration of Effect: Researchers investigated the length of time a single dose was associated with symptom changes.

Key Studies & References

  1. Arrow – Roxithromycin 150, 150 mg, coated tablets (Medsafe Data Sheet) - Clinical Particulars
  2. Azithromycin and Roxithromycin define a new family of “senolytic” drugs that target senescent human fibroblasts (Relevant for Drug A/B combination concepts)

Frequently Asked Questions (FAQ)

Common questions about Coroxin (Roxithromycin) (FAQ)

Q: How long does it usually take to start feeling better after starting Coroxin?

A: According to official patient information, symptoms of your infection typically begin to improve within a few days of starting treatment with Coroxin. However, completing the full prescribed course is typically emphasized as a necessary part of the prescribed course, even if improvement is felt sooner.


Q: Is Coroxin known to cause changes in heart rhythm?

A: Regulatory documents state that Roxithromycin has the potential to prolong the QT interval on the heart’s electrical tracing (ECG). This prolongation is associated with the risk of developing a serious, life-threatening heart rhythm issue called Torsades de Pointes, particularly if taken concurrently with certain other medications. This risk contributes to specific usage constraints for the medicine.


Q: Can people with liver issues use Coroxin?

A: Official precautions indicate that caution is required when using Coroxin if a person has liver issues. For those with severe liver impairment, the usual dosage may be subject to reduction as a regulatory requirement. Your healthcare provider determines the appropriate course based on your specific liver function.


Q: Are there age restrictions for who can use Coroxin?

A: The official product information specifies that Roxithromycin is generally not recommended for use in children who weigh less than 40 kilograms. For elderly patients, no specific adjustment to the usual dosage is typically required.


Q: Does Coroxin affect the effectiveness of birth control pills?

A: According to authoritative sources on drug interactions, Roxithromycin does not appear to interact with and affect the effectiveness of oral contraceptive pills (the pill).


Q: Can Coroxin cause allergic reactions, and what are the signs?

A: Yes, hypersensitivity reactions are known undesirable effects. Signs can include skin reactions such as rash, itching (pruritus), hives (urticaria), and swelling (angioedema). Very rarely, severe reactions like anaphylactic shock or Stevens-Johnson syndrome (SJS) have been reported in official safety profiles.


Q: What precautions should be taken if Coroxin is used by an elderly person?

A: Official dosing guidelines state that no general dosage adjustment is typically required based on age alone for older adults. However, increased monitoring for side effects, particularly moderate increases in liver enzymes, is sometimes mentioned in official literature.


Q: Does Coroxin have a specific warning about use with statin medications?

A: Caution is advised in official regulatory documents when Roxithromycin is combined with statin medications, such as Simvastatin. Patients may need to be monitored for signs of myopathy (unexplained muscle pain or weakness), and dose adjustment or temporary suspension of the statin is noted in official literature as a potential necessity.


Q: Is Coroxin a strong or broad-spectrum antibiotic?

A: Roxithromycin is an antibiotic belonging to the macrolide group. Official documents on its pharmacological properties indicate that it has a broad spectrum of activity against a range of susceptible bacteria.


Q: How long does Coroxin stay in the body after the last dose?

A: According to official pharmacokinetic properties, the medicine is eliminated from the body with a half-life (T1/2) of approximately 10 to 14 hours in healthy subjects. This measure indicates the time it takes for half of the drug to leave the bloodstream.


Q: Does Coroxin cause sun sensitivity?

A: While severe phototoxicity is not frequently listed, patients are generally advised in official labeling to be cautious about photosensitivity as a potential skin reaction that may occur when taking the medicine.


Q: Are changes in taste common when taking Coroxin?

A: Official lists of undesirable effects include both altered taste (dysgeusia) and/or loss of taste (ageusia) as known reported side effects while using the medicine.


Q: Can you take Coroxin if you are taking antacids?

A: Regulatory information indicates that Roxithromycin does not appear to interact with antacids.


Q: Is Coroxin a commonly prescribed medicine for chest infections?

A: Yes, Coroxin is officially indicated for the treatment of various susceptible infections, including those of the lower respiratory tract, which commonly involve conditions like bronchitis and pneumonia.


Q: What research has been done on the long-term use of Coroxin?

A: Official prescribing information emphasizes that treatment duration should be as short as possible, generally not exceeding two weeks. Extended use beyond this is cautioned against due to an increased risk of superinfection caused by resistant organisms.


Q: Why is Coroxin sometimes used instead of Erythromycin?

A: Studies indicate that Roxithromycin, which is chemically derived from Erythromycin, has a longer half-life and a more favorable overall pharmacokinetic profile. This longer half-life may facilitate extended dosing intervals compared to the parent drug.


Q: Is it normal to feel dizzy or lightheaded when taking Coroxin?

A: Official regulatory documents report that both dizziness and vertigo are known undesirable effects associated with the use of Roxithromycin.


Q: Can Coroxin be used to treat infections that are not bacterial?

A: No. Roxithromycin is classified as a macrolide antibiotic and is strictly indicated for the treatment of infections that are confirmed or suspected to be caused by susceptible microorganisms (bacteria).


Q: Is Coroxin linked to any digestive side effects like diarrhea?

A: Yes. According to the official safety profile, gastrointestinal side effects are among the most commonly reported undesirable effects. These can include nausea, vomiting, abdominal pain, and diarrhea.


Q: Does Coroxin cause difficulty sleeping?

A: Official safety data lists insomnia (difficulty sleeping) as a known undesirable effect that has been reported in association with the use of Roxithromycin.


Q: Why do some people need to take Coroxin for a longer period than others?

A: The length of treatment is determined by the specific type and severity of the infection being treated. For example, while many infections are treated for 5 to 10 days, specific bacterial conditions like certain Streptococcal throat infections may require a minimum course of 10 days.


Q: Can Coroxin be used for treating acne or skin conditions?

A: Yes. Coroxin is officially indicated for the treatment of susceptible infections in the skin and soft tissues, which covers conditions like impetigo and other dermatological infections.


Q: What are the most commonly reported side effects in clinical trials for Coroxin?

A: Official regulatory documents indicate that the most common side effects reported in clinical trials are related to the gastrointestinal tract. These include nausea, vomiting, abdominal pain, and diarrhea.


Q: Does Coroxin interfere with other long-term medications?

A: Yes. Roxithromycin is known to interfere with the metabolism of certain other drugs, which may lead to an increase in their plasma concentration. This interaction is noted for medications such as Warfarin, Theophylline, Ciclosporin, and Midazolam.


Q: What kind of bacteria is Coroxin generally effective against?

A: Roxithromycin is effective against a broad range of susceptible bacteria. This includes many Gram-positive aerobes (like Streptococcus pneumoniae) and certain Gram-negative organisms, as well as atypical pathogens like Mycoplasma and Chlamydia.


Q: What warnings exist regarding driving or operating machinery while taking Coroxin?

A: Official warnings state that patients should be aware of the risk of side effects such as dizziness and visual disturbances. These effects may affect the ability to drive or operate machinery.


Q: Does taking Coroxin affect results of any common medical tests?

A: While the drug is generally non-interfering, a specific interaction exists with the blood-thinning medication Warfarin. This interaction requires close monitoring of a specific lab test, the International Normalized Ratio (INR), to manage bleeding risk.


Q: Why is Coroxin prescribed for infections in the ear, nose, and throat?

A: Coroxin is officially indicated for the treatment of a variety of susceptible infections, including those that affect the ear, nose, and throat (ENT). Common examples listed in official documents include tonsillitis and sinusitis.


Q: Is it normal to feel tired while taking Coroxin?

A: Yes, official regulatory safety data lists fatigue (feeling tired) as a reported undesirable effect associated with the use of Roxithromycin.


Q: Does Coroxin interact with supplements like iron or magnesium?

A: Although no specific interaction with iron or magnesium supplements is listed in the main interaction documents, the drug's absorption is decreased by food. Because of this, it is typically directed to be taken at least 15 minutes before a meal for optimal absorption.


Q: Is there a maximum amount of time Coroxin is typically used?

A: The treatment duration is determined by the infection, but official posology guidelines establish that the course should generally not exceed a maximum of two weeks. Shorter courses, usually 5 to 10 days, are typical for most prescribed infections.


Q: What is the evidence supporting Coroxin's use in dental infections?

A: Coroxin is officially indicated for the treatment of susceptible infections. This includes orodental infections, supporting its use in certain dental conditions.


Q: How quickly is Coroxin absorbed after it is taken?

A: Pharmacokinetic data shows that Coroxin is rapidly absorbed from the gastrointestinal tract. Peak levels of the medicine in the bloodstream are typically reached within approximately 2 hours following oral administration.


Q: Does Coroxin ever cause temporary ringing in the ears?

A: Yes. Official safety data lists tinnitus (ringing in the ears) as a known undesirable effect that has been reported in association with the use of Roxithromycin.


Q: Can people with a history of digestive tract problems use Coroxin?

A: Official warnings recommend using the medicine with caution in patients who have a history of gastrointestinal issues. This is due to the potential for side effects like diarrhea or, in rare cases, a severe condition called pseudomembranous colitis.

How should Coroxin (Roxithromycin) be stored and disposed of?

Official Storage and Disposal Instructions

Coroxin (Roxithromycin) must be stored and handled strictly according to the conditions defined in the official regulatory labeling.

Storage Conditions

Requirement Specific Instruction
Temperature Store below 25 C.
Protection Keep away from direct sunlight, heat, and moisture.
Packaging Tablets must be kept in the original blister until the time of use.
Safety Keep the medicine out of the sight and reach of children.
Stability The oral suspension, once mixed, has a limited stability period of 14 days when stored below 25 C.

Disposal Mandates

All expired or unused Coroxin must be disposed of properly. Do not discard the medicine by throwing it into household waste or flushing it down a toilet or drain, as this violates environmental protection guidelines. Unused product must be returned to a pharmacist or collected via a community take-back program for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Coroxin (Roxithromycin) found in:

A-Z Index: